-1.43%
12.60%
6.04%
0.63%
8.92%
-36.72%
-18.57%
AI Spotlight on HBMN
Company Description
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies.The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES).Within fund of funds, it invests in venture capital funds.
It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts.The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries.It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage.
The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe.In case of public companies, it focuses on those which originate from its private portfolio.The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company's IPO.
It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company's Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives.The fund exits its portfolio companies through trade sale or IPO.
Market Data
| Last Price | 193 |
| Change Percentage | -1.43% |
| Open | 193.8 |
| Previous Close | 195.8 |
| Market Cap ( Millions) | 1307 |
| Volume | 2975 |
| Year High | 252.07 |
| Year Low | 155 |
| M A 50 | 183.5 |
| M A 200 | 190.13 |
Financial Ratios
| FCF Yield | -0.19% |
| Dividend Yield | 3.89% |
| ROE | 13.13% |
| Debt / Equity | 0.00% |
| Net Debt / EBIDTA | 393.57% |
| Price To Book | 0.77 |
| Price Earnings Ratio | 5.88 |
| Price To FCF | -526.57 |
| Price To sales | 5.79 |
| EV / EBITDA | -962.75 |
News
Business Breakdown
Expected Mid-Term Growth
Segment nยฐ1 -> Investment and Related Activities
Expected Growth : 8.1 %
What the company do ?
HBM Healthcare Investments AG's investment segment involves investing in publicly traded and private companies in the healthcare industry, focusing on biotechnology, pharmaceuticals, and medical technology.
Why we expect these perspectives ?
Growing demand for healthcare services, increasing investment in biotechnology and pharmaceutical R&D, and advancements in medical technology are driving growth in the healthcare industry, presenting opportunities for HBM Healthcare Investments AG's investment segment.
Hbm Healthcare Investments Ag Products
| Product Range | What is it ? |
|---|---|
| Pharmaceuticals | HBM Healthcare Investments AG invests in pharmaceutical companies that develop and commercialize innovative medicines for various therapeutic areas. |
| Biotechnology | The company invests in biotech companies that focus on research and development of novel biological products and technologies. |
| Medical Devices | HBM Healthcare Investments AG invests in companies that design and manufacture innovative medical devices for various medical specialties. |
| Digital Health | The company invests in digital health companies that develop software solutions for healthcare providers, payers, and patients. |
| Healthcare Services | HBM Healthcare Investments AG invests in healthcare service providers that offer outpatient and inpatient care, as well as healthcare management services. |
HBM Healthcare Investments AG's Porter Forces
Threat Of Substitutes
The threat of substitutes for HBM Healthcare Investments AG is moderate, as there are alternative investment options available in the healthcare sector.
Bargaining Power Of Customers
The bargaining power of customers for HBM Healthcare Investments AG is low, as the company's investment portfolio is diversified and not heavily reliant on a single customer.
Bargaining Power Of Suppliers
The bargaining power of suppliers for HBM Healthcare Investments AG is moderate, as the company relies on a diverse range of suppliers for its investment activities.
Threat Of New Entrants
The threat of new entrants for HBM Healthcare Investments AG is high, as the healthcare investment sector is attractive and has low barriers to entry.
Intensity Of Rivalry
The intensity of rivalry for HBM Healthcare Investments AG is high, as the healthcare investment sector is highly competitive and fragmented.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 5.51% |
| Debt Cost | 3.95% |
| Equity Weight | 94.49% |
| Equity Cost | 7.97% |
| WACC | 7.75% |
| Leverage | 5.83% |
HBM Healthcare Investments AG : Quality Control
HBM Healthcare Investments AG passed 3 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| MTW.L | Mattioli Woods plc provides wealth management and employee benefit services in the United Kingdom. It operates through Pension Consultancy and Administration, Investment and Asset Management, Property Management, and Employee Benefits โฆ |
| MLP.DE | MLP SE, together with its subsidiaries, provides financial brokerage and consulting services to private, corporate, and institutional clients in Germany. The company's Financial Consulting segment offers consulting services for academics โฆ |
| LTA.PA | Altamir SCA formerly known as Altamir Amboise, is a private equity firm specializing in both direct and fund of fund investments, small and mid-cap companies. In direct investing, the firm โฆ |
| TIP.MI | Tamburi Investment Partners S.p.A. is private equity firm specializing in direct and secondary direct investments. The firm also co-invests with other entrepreneurs and investors. Within direct investments, it invests in โฆ |
| BBN.SW | Bellevue Group AG provides asset management services in Switzerland, the Great Britain, Germany, and internationally. The company offers a range of products in the areas of specialized healthcare equity, selected โฆ |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
๐ฅ
MLP
A-Score
1-Year Total Return ->
๐ฅ
HBM Healthcare Investments
A-Score
1-Year Total Return ->
๐ฅ
Altamir
A-Score
1-Year Total Return ->
4
Bellevue
A-Score
1-Year Total Return ->
5
Tamburi Investment Partners
A-Score
1-Year Total Return ->
6
